CDSCO approves Sanofi’s Qfitlia for haemophilia A and B in India EP News Bureau Oct 21, 2026 Fitusiran is indicated for routine prophylaxis to prevent or reduce bleeding episodes in adults and adolescents aged 12 years and…
